Early clearance vs persistence of de novo donor-specific antibodies following lung transplantation
Islam, AK, Sinha, N, DeVos, JM, Kaleekal, TS, Jyothula, SS, Teeter, LD, Nguyen, DTM, Eagar, TN, Moore, LW, Puppala, M, Wong, STC, Knight, RJ, Frost, AE, Graviss, EA & Osama Gaber, A 2017, Clinical Transplantation. DOI:
Incidence and Factors Associated with De Novo DSA After BK Viremia in Renal Transplant Recipients
Patel, SJ, Kuten, SA, Knight, RJ, Graviss, EA, Nguyen, DTM & Gaber, AO 2017, . in Clinical Transplants 2016. Terasaki Research Institute, Los Angeles, California, pp. 103-109.
Combination Drug Products for HIV—A Word of Caution for the Transplant Clinician
Patel, SJ, Kuten, SA, Musick, WL, Gaber, AO, Monsour, HP & Knight, R 2016, American Journal of Transplantation, vol 16, no. 8, pp. 2479-2482. DOI:
Intermediate-Term Outcomes of Dual Adult versus Single-Kidney Transplantation: Evolution of a Surgical Technique
Islam, AK, Knight, RJ, Mayer, WA, Hollander, AB, Patel, S, Teeter, LD, Graviss, EA, Saharia, A, Podder, H, Asham, EH & Gaber, AO 2016, The Journal of Heart Transplantation, vol 2016, pp. 2586761. DOI:
Disparate rates of acute rejection and donor-specific antibodies among high-immunologic risk renal transplant subgroups receiving antithymocyte globulin induction
Patel, SJ, Suki, WN, Loucks-DeVos, J, Graviss, EA, Nguyen, DT, Knight, RJ, Kuten, SA, Moore, LW, Teeter, LD, Gaber, LW & Gaber, AO 2016, Transplant International, vol 29, no. 8, pp. 897-908. DOI:
Excessive Weight Gain After Pancreas Transplant: Transitioning from Type 1 to Type 2 Diabetes?
Islam, AK, Lawless, A, Teeter, LD, Graviss, E, Victor, III, DW, Sadhu, A, Patel, SJ, Gaber, AO & Knight, R 2015, American Journal of Transplantation, vol 2015, no. 15 (suppl3), 2015; 15.
Barriers to preemptive renal transplantation: a single center questionnaire study
Knight, RJ, Teeter, LD, Graviss, EA, Patel, SJ, DeVos, JM, Moore, LW & Gaber, AO 2015, Transplantation, vol 99, no. 3, pp. 576-579. DOI:
Observations on the use of cidofovir for BK virus infection in renal transplantation
Kuten, SA, Patel, SJ, Knight, RJ, Gaber, LW, Devos, JM & Gaber, AO 2015, Transplant Infectious Disease, vol 16, no. 6, pp. 975-983. DOI:
Intermediate-term graft loss after renal transplantation is associated with both donor-specific antibody and acute rejection
Devos, JM, Gaber, AO, Teeter, LD, Graviss, EA, Patel, SJ, Land, GA, Moore, LW & Knight, RJ 2014, Transplantation, vol 97, no. 5, pp. 534-540. DOI:
Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin
Patel, SJ, Kuten, SA, Knight, RJ, Hong, DM & Gaber, AO 2014, Journal of Heart Transplantation, vol 2014, pp. 342319. DOI:
A surgeons' guide to renal transplant immunopathology, immunology, and immunosuppression
, Knight, RJ & Patel, SJ 2013, Surgical Clinics of North America, vol 93, no. 6, pp. 1293-1307. DOI:
Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy
, Gaber, LW, Patel, SJ, Devos, JM, Moore, LW & Gaber, AO 2013, Transplantation, vol 96, no. 7. DOI:
Cross-sectional and case-control analyses of the association of kidney function staging with adverse postoperative outcomes in general and vascular surgery
, Moore, LW, Aloia, TA, Suki, WN, Jones, SL, Graviss, EA, Knight, RJ & Bass, BL 2013, Annals of Surgery, vol 258, no. 1, pp. 169-177. DOI:
Comparison of laparoendoscopic single site (LESS) and conventional laparoscopic donor nephrectomy at a single institution
Stamatakis, L, Mercado, MA, Choi, JM, Sanchez, EJ, Gaber, AO, Knight, RJ, Mayer, WA & Link, RE 2013, BJU International, vol 112, no. 2, pp. 198-206. DOI:
Outcomes of living donor renal transplants with a negative cross-match and pretransplant donor-specific antibody
Knight, RJ, Devos, JM, Patel, SJ, Land, G, Moore, LW, Gaber, L & Gaber, AO 2013, Transplantation Proceedings, vol 45, no. 4, pp. 1399-1401. DOI:
Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: A single-center retrospective analysis
, Gaber, LW, Patel, SJ, Devos, JM, Moore, LW & Gaber, AO 2013, Transplantation, vol 95, no. 7, pp. 949-954. DOI:
Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation
Devos, JM, Gaber, AO, Knight, RJ, Land, GA, Suki, WN, Gaber, LW & Patel, SJ 2012, Kidney International, vol 82, no. 5, pp. 598-604. DOI:
Increased mortality of solid organ transplant recipients with H1N1 infection: A single center experience
Gainer, SM, Patel, SJ, Seethamraju, H, Moore, LW, Knight, RJ & Gaber, AO 2012, Clinical Transplantation, vol 26, no. 2, pp. 229-237. DOI:
De novo donor specific antibodies and patient outcomes in renal transplantation.
DeVos, JM, Patel, SJ, Burns, KM, Dilioglou, S, Gaber, LW, Knight, RJ, Gaber, AO & Land, GA 2011, Clinical transplants, pp. 351-358.
Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60yr of age
Patel, SJ, Knight, RJ, Suki, WN, Abdellatif, A, Duhart, BT, Krauss, AG, Mannan, S, Nezakatgoo, N & Osama Gaber, A 2011, Clinical Transplantation, vol 25, no. 3. DOI: